Dr Renee Melva Ward, MD | |
500 Ray C Hunt Dr, Charlottesville, VA 22903-2981 | |
(434) 924-2103 | |
(434) 243-6329 |
Full Name | Dr Renee Melva Ward |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 23 Years |
Location | 500 Ray C Hunt Dr, Charlottesville, Virginia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558538751 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
University Of Virginia Medical Center | Charlottesville, VA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.
A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.
› Verified 3 days ago
Entity Name | University Of Virginia Physicians Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.
A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Renee Melva Ward, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Dr Renee Melva Ward, MD 500 Ray C Hunt Dr, Charlottesville, VA 22903-2981 Ph: (434) 924-2103 |
News Archive
Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.
A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health.
While refining ways to grow arterial endothelial cells in the lab, a regenerative biology team at the Morgridge Institute for Research at the University of Wisconsin-Madison unexpectedly unearthed a powerful new model for studying a hallmark of vascular disease.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies.
Mylan Inc. today announced that its business Mylan Institutional has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Dexrazoxane for Injection, packaged in 250 mg and 500 mg Single-use Vials. This product is the generic version of Pharmacia & Upjohn's Zinecard® for Injection, a chemoprotective agent.
› Verified 3 days ago
Donald J. Dudley, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22908 Phone: 434-924-2500 Fax: 434-244-9487 | |
Christian A. Chisholm, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1204 W Main St, Charlottesville, VA 22903 Phone: 434-924-2500 Fax: 434-244-9487 | |
Jennifer Doorey, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 304, Charlottesville, VA 22903 Phone: 434-243-4570 Fax: 434-295-5491 | |
Evan Jacob Kraus, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Peter Jefferson Pkwy, Charlottesville, VA 22911 Phone: 434-977-4488 | |
Charles N. Landen Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1240 Lee St, Charlottesville, VA 22908 Phone: 434-924-5100 Fax: 434-982-1840 | |
Dr. Linnea Rose Goodman, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 4100 Olympia Cir Ste 201, Charlottesville, VA 22911 Phone: 434-220-6620 Fax: 434-220-6621 | |
Ms. Whitney Dijon Archie-patrick, FNP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2955 Ivy Rd Ste 304, Charlottesville, VA 22903 Phone: 434-243-4570 Fax: 434-295-5491 |